Monitoring of Haemophilus influenzae isolated from carriage, lower respiratory tract infections and blood over a six-month period in Belgium.
H. influenzae infection
ftsI gene sequencing
Beta-lactam resistance
Journal
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297
Informations de publication
Date de publication:
23 Jul 2024
23 Jul 2024
Historique:
received:
23
04
2024
accepted:
08
07
2024
medline:
23
7
2024
pubmed:
23
7
2024
entrez:
23
7
2024
Statut:
aheadofprint
Résumé
H. influenzae carriage may evolve into respiratory or systemic infections. However, no surveillancesystem is in place in Belgium to monitor carriage strains. This study provides a detailed description of H. influenzae strains isolated from both carriage and lower respiratory infections, collected during a six-month national surveillance. Subsequently, a comparison is conducted with invasive isolates collected during the same period at the National Reference Centre (NRC). From November 2021 to April 2022, 39 clinical laboratories collected 142 and 210 strains of H. influenzae from carriage and infection, respectively, and 56 strains of blood were submitted to the NRC. In each group, the biotype II comprised more than 40%, followed by biotypes III and I. The majority of strains were non-typeable H. influenzae, with a notable increase in the number of encapsulated strains in the invasive group (14.3% vs. 1-2%). A beta-lactamase was identified in 18.5% and 12.5% of surveillance and invasive strains, respectively. Resistance to the amoxicillin-clavulanic acid combination accounted for 7% in the surveillance strains and 10.7% in invasive strains. The overall resistance to third-generation cephalosporins at 1.2% is consistent with rates observed in other European countries. Of particular significance is the identification of mutations in the ftsI gene in both carriage and infected strains, which are associated with high-level beta-lactam resistance. NRC must engage in regular and systematic monitoring of beta-lactam susceptibility of H. influenzae to guarantee safe empiric therapy in severe cases and identify potential transitions from low-level to high-level resistance in the future.
Identifiants
pubmed: 39042345
doi: 10.1007/s10096-024-04900-0
pii: 10.1007/s10096-024-04900-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Mukundan D, Ecevit Z, Patel M, Marrs CF, Gilsdorf JR (2007) Pharyngeal colonization dynamics of Haemophilus influenzae and Haemophilus haemolyticus in healthy adult carriers. J Clin Microbiol 45(10):3207–3217. https://doi.org/10.1128/JCM.00492-07
doi: 10.1128/JCM.00492-07
pubmed: 17687018
pmcid: 2045313
King P (2012) Haemophilus influenzae and the lung (Haemophilus and the lung). Clin Translational Med 1(1):10. https://doi.org/10.1186/2001-1326-1-10
doi: 10.1186/2001-1326-1-10
Brueggemann AB, van Rensburg J, Shaw MJ, McCarthy D, Jolley ND, Maiden KA, van der Linden MCJ, Amin-Chowdhury MPG, Bennett Z, Borrow DE, Brandileone R, Broughton MC, Campbell K, Cao R, Casanova B, Choi C, Chu EH, Clark YW, Claus SA, Coelho H, Zhou J, F (2021) Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health 3(6):e360–e370. https://doi.org/10.1016/S2589-7500(21)00077-7
doi: 10.1016/S2589-7500(21)00077-7
pubmed: 34045002
pmcid: 8166576
Kramer A, Schwebke I, Kampf G (2006) How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6:130. https://doi.org/10.1186/1471-2334-6-130
doi: 10.1186/1471-2334-6-130
pubmed: 16914034
pmcid: 1564025
Jacquinet S, Martiny D, Prevost B, Grammens T (2022) Surveillance épidémiologique des infections invasives à Haemophilus influenzae. Sciensano, Brussels
Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, Sunakawa K, Inoue M, Konno M (2001) Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 45(6):1693–1699. https://doi.org/10.1128/AAC.45.6.1693-1699.2001
doi: 10.1128/AAC.45.6.1693-1699.2001
pubmed: 11353613
pmcid: 90533
Brussels Environment AMCRAARSIA, CHU Liège; DGZ, EARS-BE; ESAC-Net Study Group, FASFC; FPS Public Health; ISSep; ILVO, NRL-AMR (Sciensano), Salmonella NRC, Mycobacteria (Sciensano); NRC Sexually Transmitted Infections; NRC Staphylococci; Mycology and aerobiology (Sciensano); Sciensano; SPGE; SPW; Statistical analysis and data compilation (Sciensano); TC-MDRO; UGent; Veterinary Epidemiology (Sciensano) BELMAP One Health report on antimicrobial use and resistance in Belgium 2022
Jacquinet S, Martiny D, Prevost B, Grammens T (2019–2021) Surveillance épidémiologique Des infections invasives à Haemophilus influenzae. Sciensano, Brussels
WHO (2024) WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance https://www.who.int/publications/i/item/9789240093461 . Accessed 28 May 2024
Cornaglia G, Courcol R, Hermann J-L, Kahlmeter G, Peigue-Lafeuille H, Vila J (2012) European Manual of Clinical Microbiology (2012) SFM, ESCMID
Skaare D, Lia A, Hannisdal A, Tveten Y, Matuschek E, Kahlmeter G, Kristiansen BE (2015) Haemophilus influenzae with non-beta-lactamase-mediated Beta-lactam resistance: Easy to find but hard to categorize. J Clin Microbiol 53(11):3589–3595. https://doi.org/10.1128/JCM.01630-15
doi: 10.1128/JCM.01630-15
pubmed: 26354813
pmcid: 4609732
Fernando SA, Pang S, McKew GL, Phan T, Merlino J, Coombs GW, Gottlieb T (2020) Evaluation of the Haemophilus influenzae EUCAST and CLSI disc diffusion methods to recognize Aminopenicillin and amoxicillin/clavulanate resistance. J Antimicrob Chemother 75(9):2594–2598. https://doi.org/10.1093/jac/dkaa229
doi: 10.1093/jac/dkaa229
pubmed: 32585694
Dabernat H, Delmas C, Seguy M, Pelissier R, Faucon G, Bennamani S, Pasquier C (2002) Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 46(7):2208–2218. https://doi.org/10.1128/AAC.46.7.2208-2218.2002
doi: 10.1128/AAC.46.7.2208-2218.2002
pubmed: 12069976
pmcid: 127296
Sottnek FO, Albritton WL (1984) Haemophilus influenzae biotype VIII. J Clin Microbiol 20(4):815–816. https://doi.org/10.1128/jcm.20.4.815-816.1984
doi: 10.1128/jcm.20.4.815-816.1984
pubmed: 6333437
pmcid: 271439
Ekinci E, Willen L, Rodriguez Ruiz JP, Maertens K, Van Heirstraeten L, Serrano G, Wautier M, Deplano A, Goossens H, Van Damme P, Beutels P, Malhotra-Kumar S, Martiny D, Theeten H (2023) Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016–2018). Front Microbiol 14:1160073. https://doi.org/10.3389/fmicb.2023.1160073
doi: 10.3389/fmicb.2023.1160073
pubmed: 37168112
pmcid: 10164969
Carrera-Salinas A, González-Díaz A, Calatayud L, Mercado-Maza J, Puig C, Berbel D, Càmara J, Tubau F, Grau I, Domínguez MÁ, Ardanuy C, Martí S (2021) Epidemiology and population structure of Haemophilus influenzae causing invasive disease. Microb Genomics 7(12):000723. https://doi.org/10.1099/mgen.0.000723
doi: 10.1099/mgen.0.000723
McElligott M, Meyler K, Bennett D, Mulhall R, Drew RJ, Cunney R (2020) Epidemiology of Haemophilus influenzae in the Republic of Ireland, 2010–2018. Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol 39(12):2335–2344. https://doi.org/10.1007/s10096-020-03971-z
doi: 10.1007/s10096-020-03971-z
Wall EC, Taha MK (2023) Haemophilus influenzae is fighting back: is serotype a an emerging threat? Lancet Infect Dis 23(10):1106–1108. https://doi.org/10.1016/S1473-3099(23)00204-9
doi: 10.1016/S1473-3099(23)00204-9
pubmed: 37356442
Slack MPE, Cripps AW, Grimwood K, Mackenzie GA, Ulanova M (2021) Invasive Haemophilus influenzae infections after 3 decades of hib protein Conjugate Vaccine Use. Clin Microbiol Rev 34(3):e0002821. https://doi.org/10.1128/CMR.00028-21
doi: 10.1128/CMR.00028-21
pubmed: 34076491
Kiedrowska M, Foryś WJ, Gołębiewska A, Waśko I, Ronkiewicz P, Kuch A, Wróbel-Pawelczyk I, Wroczyński M, Hryniewicz W, Skoczyńska A (2022) Antimicrobial resistance among Haemophilus influenzae isolates responsible for lower respiratory tract infections in Poland, 2005–2019. Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol 41(6):961–969. https://doi.org/10.1007/s10096-022-04457-w
doi: 10.1007/s10096-022-04457-w
Giufrè M, Cardines R, Marra M, Carollo M, Cerquetti M, Stefanelli P (2023) Antibiotic susceptibility and molecular typing of invasive Haemophilus influenzae isolates, with emergence of Ciprofloxacin Resistance, 2017–2021, Italy. Microorganisms 11(2):315. https://doi.org/10.3390/microorganisms11020315
doi: 10.3390/microorganisms11020315
pubmed: 36838281
pmcid: 9965257
Nürnberg S, Claus H, Krone M, Vogel U, Lâm TT (2021) Cefotaxime resistance in invasive Haemophilus influenzae isolates in Germany 2016-19: prevalence, epidemiology and relevance of PBP3 substitutions. J Antimicrob Chemother 76(4):920–929. https://doi.org/10.1093/jac/dkaa557
doi: 10.1093/jac/dkaa557
pubmed: 33501993
Tønnessen R, García I, Debech N, Lindstrøm JC, Wester AL, Skaare D (2022) Molecular epidemiology and antibiotic resistance profiles of invasive Haemophilus influenzae from Norway 2017–2021. Front Microbiol 13:973257. https://doi.org/10.3389/fmicb.2022.973257
doi: 10.3389/fmicb.2022.973257
pubmed: 36106084
pmcid: 9467436
Straker K, Wootton M, Simm AM, Bennett PM, MacGowan AP, Walsh TR (2003) Cefuroxime resistance in non-beta-lactamase Haemophilus influenzae is linked to mutations in ftsI. J Antimicrob Chemother 51(3):523–530. https://doi.org/10.1093/jac/dkg107
doi: 10.1093/jac/dkg107
pubmed: 12615852
Jakubu V, Malisova L, Musilek M, Pomorska K, Zemlickova H (2021) Characterization of Haemophilus influenzae strains with non-enzymatic resistance to β-Lactam antibiotics caused by mutations in the PBP3 gene in the Czech Republic in 2010–2018. Life (Basel Switzerland) 11(11):1260. https://doi.org/10.3390/life11111260
doi: 10.3390/life11111260
pubmed: 34833138
Su PY, Cheng WH, Ho CH (2023) Molecular characterization of multidrug-resistant non-typeable Haemophilus influenzae with high-level resistance to cefuroxime, levofloxacin, and trimethoprim-sulfamethoxazole. BMC Microbiol 23(1):178. https://doi.org/10.1186/s12866-023-02926-6
doi: 10.1186/s12866-023-02926-6
pubmed: 37407940
pmcid: 10320927
Hegstad K, Mylvaganam H, Janice J, Josefsen E, Sivertsen A, Skaare D (2020) Role of horizontal gene transfer in the development of Multidrug Resistance in Haemophilus influenzae. mSphere 5(1):e00969–e00919. https://doi.org/10.1128/mSphere.00969-19
doi: 10.1128/mSphere.00969-19
pubmed: 31996416
pmcid: 6992377
Maughan H, Redfield RJ (2009) Extensive variation in natural competence in Haemophilus influenzae. Evolution 63(7):1852–1866. https://doi.org/10.1111/j.1558-5646.2009.00658.x
doi: 10.1111/j.1558-5646.2009.00658.x
pubmed: 19239488
Michel C, Argudín MA, Wautier M, Echahidi F, Prevost B, Vandenberg O, Martiny D, Hallin M (2024) Multiple interspecies recombination events documented by whole-genome sequencing in multidrug-resistant Haemophilus influenzae clinical isolates. Access Microbiol 6(2):000649v3. https://doi.org/10.1099/acmi.0.000649.v3
doi: 10.1099/acmi.0.000649.v3